Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04150718 · ClinicalTrials.gov registry record · NA
Role of Slow-wave Activity and Plasticity in MDD
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT04150718: Completed NA study, sponsored by University of Pennsylvania.
NCT04150718 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04150718, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The hypothesis underlying this proposal is that deficits of synaptic plasticity underlie the slow-wave activity (SWA) abnormalities observed n major depressive disorder (MDD), and that manipulating SWA may serve to circumvent these deficits by facilitating an increase in synaptic strength via the inhibition of synaptic down-scaling, thereby improving plasticity and mood.
Interventions
- BEHAVIORAL slow-wave disruption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2020-03-04 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04150718
The ClinicalTrials.gov registry entry for NCT04150718 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which slow-wave disruption is the first listed.
NCT04150718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04150718 about?
NCT04150718 is a clinical study titled "Role of Slow-wave Activity and Plasticity in MDD". The hypothesis underlying this proposal is that deficits of synaptic plasticity underlie the slow-wave activity (SWA) abnormalities observed n major depressive disorder (MDD), and that manipulating SWA may serve to circumvent these deficits by facilitating an increase in synaptic strength via the in...
What is the current status of trial NCT04150718?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2020-03-04. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT04150718?
The interventions under investigation include: slow-wave disruption (BEHAVIORAL).
Who is sponsoring clinical trial NCT04150718?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.